Sudden Death Associated with Dexedrine-New Black Box Warning Issued
The Food and Drug Administration and GlaxoSmithKline recently sent notice to healthcare professionals and pharmacists about a new black box warning on Dexedrine (dextroamphetamine sulfate). The drug, typically prescribed to treat Attention-Deficit Hyperactivity Disorder and narcolepsy, has been show
@large.jpg)
The Food and Drug Administration and GlaxoSmithKline recently sent notice to healthcare professionals and pharmacists about a new black box warning on Dexedrine (dextroamphetamine sulfate). The drug, typically prescribed to treat Attention-Deficit Hyperactivity Disorder and narcolepsy, has been shown to cause sudden death in association with CNS stimulant treatment in children and adolescents with heart problems.
